Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma

Clinical trial NCT05656144 · UNKNOWN

Trial details

NCT number: NCT05656144
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2023-02-01
Primary completion: 2024-12-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.